Display Settings:

Format

Send to:

Choose Destination
    Vaccine. 2011 Dec 9;30(1):1-4. Epub 2011 Nov 7.

    Comparison of multiple estimates of efficacy for influenza vaccine.

    Source

    Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada. loebm@mcmaster.ca

    Abstract

    Influenza vaccine trials typically report vaccine efficacy for infection-confirmed symptomatic illness. Data on indirect vaccine efficacy for susceptibility, the degree of vaccine protection to susceptibles, or indirect vaccine efficacy for illness given infection, are sparse. Using inactivated influenza vaccine randomized trial data, we calculated indirect vaccine efficacy for susceptibility of 20% [95% CI 9-30] and indirect vaccine efficacy for illness among infected persons 12% [95% CI 2-22], values inferior to a direct vaccine efficacy for infection-confirmed symptomatic illness of 55% [95% CI -21 to 84] and an indirect effect of 61% [95% CI 8-83]. Such data reveal variance in protective efficacy of the vaccine for multi-dimensional direct and indirect efficacy measures.

    Copyright © 2011 Elsevier Ltd. All rights reserved.

    PMID:
    22098676
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk